Clinical Trial Update: Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab, methotrexate, vincristine, procarbazine, and cytarabine with or without radiation for primary CNS lymphoma; results posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• METHOTREXATE (METHOTREXATE)
• Procarbazine Hydrochloride (procarbazine hydrochloride)
• Rituximab (rituximab)
• Vincristine sulfate (VINCRISTINE SULFATE)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13